
Applications of HER2+ organoids and NAMs to study breast cancer
HER2-positive breast cancer represents about one quarter of breast malignancies and is driven by amplification of

HER2-positive breast cancer represents about one quarter of breast malignancies and is driven by amplification of

Triple-negative breast cancer (TNBC) is a distinct pathological subtype defined by the absence of estrogen receptor

Obesity and its related metabolic diseases, such as type 2 diabetes, represent a growing global health

In our previous article, we outlined the main in vitro liver models, immortalized cell lines such

In vitro liver models are central to drug discovery and toxicology, enabling controlled evaluation of metabolism,

Liver disease and drug-induced liver injury remain critical challenges in medicine and pharmaceutical development, demanding models

Re-Engineering the Liver Microenvironment In the first article of this series, we discussed the limitations of

The liver organoid is transforming how researchers approach drug discovery and safety testing. As miniature, three-dimensional

Understanding how the body processes fats is central to tackling obesity, type 2 diabetes, and fatty

Breast cancer remains the most common malignancy in women worldwide, and progress in treatment increasingly depends